Autoantigen-specific B cell activation in Fas-deficient rheumatoid factor immunoglobulin transgenic mice

被引:59
作者
Wang, HW
Shlomchik, MJ
机构
[1] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA
[2] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA
关键词
autoimmunity; systemic lupus; B cell tolerance; autoantibody; IgG;
D O I
10.1084/jem.190.5.639
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In systemic autoimmune disease, self-tolerance fails, leading to autoantibody production. A central issue in immunology is to understand the origins of activated self-reactive B cells. We have used immunoglobulin (Ig) transgenic mice to investigate the regulation of autoreactive B cells with specificity for self-IgG2a (the rheumatoid factor [RF] specificity) to understand how normal mice regulate RF autoantibodies and how this falls in autoimmune mice. We previously showed that normal mice do not tolerize the AM14 RF clone, nor do they appear to activate it. Here we show that in Fas-deficient autoimmune mice, the picture is quits different. RF B cells are activated to divide and secrete, but only when the autoantigen is present. Thus, B cells that are ignored rather than anergized in normal mice can be stimulated to produce autoantibody in Fas-deficient mice. This demonstrates a novel developmental step at which intact Fas-Fas ligand signaling is required to regulate B cells in order to prevent autoimmunity. These data also establish the relevance of ignorant self-specific B cells to autoantibody production in disease and prove that in the case of the RF specificity, the nominal autoantigen IgG2a is the driving autoantigen in vivo.
引用
收藏
页码:639 / 649
页数:11
相关论文
共 91 条
  • [51] EXPRESSION AND FUNCTION OF THE MURINE CD95/FASR/APO-1 RECEPTOR IN RELATION TO B-CELL ONTOGENY
    ONEL, KB
    TUCEKSZABO, CL
    ASHANY, D
    LACY, E
    NIKOLICZUGIC, J
    ELKON, KB
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (10) : 2940 - 2947
  • [52] Pewzner-Jung Y, 1998, J IMMUNOL, V161, P4634
  • [53] PISETSKY DS, 1982, J IMMUNOL, V128, P2322
  • [54] RADIC MZ, 1991, J IMMUNOL, V146, P176
  • [55] RANDEN I, 1992, J IMMUNOL, V148, P3296
  • [56] RATHMELL JC, 1994, J IMMUNOL, V153, P2831
  • [57] CD95 (FAS) DEPENDENT ELIMINATION OF SELF-REACTIVE B-CELLS UPON INTERACTION WITH CD4(+) T-CELLS
    RATHMELL, JC
    COOKE, MP
    HO, WY
    GREIN, J
    TOWNSEND, SE
    DAVIS, MM
    GOODNOW, CC
    [J]. NATURE, 1995, 376 (6536) : 181 - 184
  • [58] RAZ E, 1989, J IMMUNOL, V142, P3076
  • [59] Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO
  • [60] 2-P